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Transintestinal cholesterol efﬂux (TICE)Transintestinal cholesterol efﬂux (TICE) has been proposed to represent a non-hepatobiliary route of choles-
terol secretion directly “from blood to gut” and to play a physiologically signiﬁcant role in excretion of neutral
sterols, but so far little is known about the proteins involved in the process. We have previously observed that
apolipoprotein A-1 (apoA-1) synthesized by enterocytes of the small intestine is mainly secreted apically into
the gut lumen during fasting where its assembly into chylomicrons and basolateral discharge is at a minimal
level. In the present work we showed, both by immunomicroscopy and subcellular fractionation, that a frac-
tion of the apically secreted apoA-1 in porcine small intestine was not released from the cell surface but in-
stead deposited in the brush border. Cholesterol was detected in immunoisolated microvillar apoA-1, and it
was partially associated with detergent resistant membranes (DRMs), indicative of localization in lipid raft
microdomains. The apolipoprotein was not readily released from microvillar vesicles by high salt or by incu-
bation with phosphatidylcholine-speciﬁc phospholipase C or trypsin, indicating a relatively ﬁrm attachment
to the membrane bilayer. However, whole bile or taurocholate efﬁciently released apoA-1 at low concentra-
tions that did not solubilize the transmembrane microvillar protein aminopeptidase N. Based on these ﬁnd-
ings and the well known role played by apoA-1 in extrahepatic cellular cholesterol removal and reverse
cholesterol transport (RCT), we propose that brush border-deposited apoA-1 in the small intestine acts in
TICE by mediating cholesterol efﬂux into the gut lumen.
© 2011 Elsevier B.V. All rights reserved.1. Introduction
Apolipoprotein A-1 (apoA-1) is the major apolipoprotein of high
density lipoproteins (HDL) and belongs to the class of exchangeable
apolipoproteins capable of moving between different lipoproteins
[5,48]. The common structural motif of these proteins is the amphi-
pathic α-helix, enabling them to bind reversibly to lipid surfaces as
well as to self-assemble when in solution [31,36,38]. Functionally,
apoA-1 plays an essential role in cellular cholesterol efﬂux and re-
verse cholesterol transport (RCT) and is thus a key player in the over-
all cholesterol homeostasis [21]. At the cell surface, apoA-1's interactive
partner in removal of free cholesterol is mainly thought to be the ATP-
binding cassette transporter A1 (ABCA1), an integralmembrane protein
exporting cholesterol and phospholipids [7]. In the process, lipid-free/
poor apoA-1 becomes lipidated, forming discoidal HDL particles that
are subsequently remodeled in a stepwise manner to the other types
of HDL circulating in the plasma [21].
In addition to the liver, the small intestine is a major site for syn-
thesis and export of lipoproteins [29,30,35]. During absorption ofand Molecular Medicine, The
200 Copenhagen N, Denmark.
.
l rights reserved.dietary fat apoA-1, together with other apolipoproteins, including
apolipoprotein B-48 (apoB-48) is assembled into chylomicrons in
the endoplasmic reticulum of the enterocytes. From here, they are
transferred along the secretory pathway to the Golgi complex and ﬁ-
nally discharged from the basolateral side of the cells toward the
lymph system. Enterocytic synthesis of apoA-1 and apoB-48 is not
acutely regulated neither by dietary triglyceride nor biliary lipid
[18–20]. Thus, a substantial small intestinal synthesis also occurs in
the fasting state despite the decreased amounts of fat transported,
possibly owing to the fact that fat feeding increases the size, but not
the number, of chylomicrons produced in the small intestine [28]. In
the fasting state, a major fraction of the apolipoproteins synthesized
by enterocytes therefore remains non-lipoprotein bound and is se-
creted in a free state [1,34,37]. Under these conditions, we previously
observed that a high proportion of lipid free/poor apoA-1 and apoB-
48 is not secreted basolaterally but apically through the brush border
to the gut lumen [16].
The brush border of the jejunum is primarily known to be themajor
site for absorption of dietary/biliary cholesterol, but interestingly the
proximal part of the small intestine has also been proposed to act as a
site for cholesterol excretion by a mechanism termed transintestinal
cholesterol efﬂux (TICE) [9,42,46]. Unlike RCT, TICE thereby represents
a non-hepatobiliary, direct route of cholesterol secretion “from blood
to gut”. Historically, evidence supporting such an alternative excretion
531E.M. Danielsen et al. / Biochimica et Biophysica Acta 1818 (2012) 530–536mechanism has accumulated from both animal and human studies,
where biliary obstruction/diversion did not prevent the appearance of
fecal neutral sterols. More recently, TICE has been directly demonstrat-
ed in experiments using perfusion of isolated intestinal segment, and it
has been estimated to contribute about one-third of the overall neutral
sterol secretion in humans, whereas in mice it may play an even more
prominent role in cholesterol secretion than the hepatobiliary route
[43,44]. In addition, non-biliary excretion of neutral sterols has been
revealed by targeted depletion of hepatic cholesterol esteriﬁcation [8].
A connection to the general fatmetabolismwas implied by the observa-
tion that activation of the peroxisome proliferator-activated receptor δ
(PPARδ) increased TICE more than two-fold [47]. However, key molec-
ular players involved in TICE so far remain elusive in that no apparent
involvement could be establishedwith candidate cholesterol transport-
ing proteins such as scavenger receptor class B type I (SR-BI), Niemann–
Pick C1-like 1 protein (NPC1L1), or members of the ATP-binding cas-
sette transporters ABCA1, ABCG1, or ABCG5/8 [42,46].
The aim of the present work was to study in closer detail the fate
of apically secreted apoA-1 in small intestinal enterocytes. We ob-
served that substantial amounts of the apolipoprotein are not directly
released to the gut lumen but instead deposited in the brush border.
The brush border-associated apolipoprotein was partially associated
with detergent-resistant membranes (DRMs), indicating a localiza-
tion in lipid rafts, and cholesterol was detected in immunoisolated
microvillar apoA-1. ApoA-1 was not readily released from microvillar
vesicles by trypsin, phosphatidylcholine-speciﬁc phospholipase C, or
high salt, implying a relatively strong association with the membrane,
but it could be solubilized by low concentrations of whole bile or
taurocholate. Since these agents have previously also been shown to
promote TICE, we propose that apoA-1, synthesized by the entero-
cytes in the fasting state and deposited in the brush border, may
take part in this important physiological process.
2. Materials and methods
2.1. Materials
Rabbit antibodies to human apolipoprotein A-1 (apoA-1), human
apolipoprotein B (apoB), and secondary antibodies for immunoblot-
ting and immunogold electron microscopy were from DAKO (www.
dako.dk), a rabbit antibody to intestinal alkaline phosphatase (IAP)
was from AbD Serotec (www.biogenesis.co.uk/), and Alexa-coupled
anti-rabbit antibodies and ProLong Gold antifade reagent with DAPI
were from Invitrogen (www.invitrogen.com). Rabbit antibodies to
human apoA-1 and aminopeptidase N were prepared as previously
described [11,26]. ApoA-1 from human plasma (>85% pure), bovine
bile, and sodium taurocholate were from Sigma-Aldrich (www.
sigmaaldrich.com), and Protein A Sepharose CL-4B was from GE
Healthcare (wwwgehealthcare.com). Pig small intestines were surgi-
cally removed by licensed staff from anesthetized animals that were
fasted overnight at the Department of Experimental Medicine, the
Panum Institute, University of Copenhagen.
2.2. Immunoﬂuorescence microscopy
10–20 cm pieces of the small intestine were taken 1–2 m from the
Pyloris and rinsed in ice cold RPMI medium. Mucosal segments of
about 0.1 g were then rapidly excised and ﬁxed in 4% paraformalde-
hyde in 0.1 M sodium phosphate, pH 7.2 (buffer A), for 2 h at 4 °C.
Following a rinse in buffer A they were frozen in precooled 2-
methylbutane and sectioned in a Leica CM1850 cryostat at −20 °C.
For immunolabeling of apoA-1 or apoB, the sections were incubated
for 1 h at room temperature with the respective primary antibodies
(1:200–1000 dilution) in 50 mM Tris–HCl, 150 mM NaCl, 0.5% oval-
bumin, 0.1% gelatin, 0.05% Tween 20, 0.2% telostan gelatin, pH 7.2
(buffer B), followed by a second incubation for 1 h with Alexa-coupled antibodies to rabbit IgG (1:200 dilution in buffer B). Controls
with omission of primary antibodies were routinely included in all
experiments. The sections were ﬁnally mounted in antifade medium
and examined in a Leica DM 4000B microscope ﬁtted with a Leica
DC 300FX digital camera.
2.3. Immunogold electron microscopy
For ultracryosectioning, mucosal sections were ﬁxed in 4% para-
formaldehyde as described above. After a rinse in buffer A they
were immersed overnight in 2.3 M sucrose, containing 1% parafor-
maldehyde. After a rinse in buffer A they were mounted on a metal
pin and frozen in liquid nitrogen. Sections were cut in a RMC MT
6000-XL ultramicrotome, collected with a sucrose droplet, and at-
tached to formvar-coated nickel grids. Labeling was performed with
anti-apoA-1 antibodies (1:100 dilution) for 1 h followed by labeling
with secondary gold-coupled antibodies (1:100 dilution) for 1 h, es-
sentially as previously described [24]. Controls with omission of pri-
mary antibodies were routinely included in all experiments. The
sections were examined in a Zeiss EM 900 electron microscope ﬁtted
with a Mega View II digital camera.
2.4. Subcellular fractionation of intestinal mucosa and immunoisolation
of apoA-1
Mucosa was scraped from 5 to 10 cm pieces of pig jejunum and
fractionated into soluble, Mg2+-precipitated membranes (basolateral
and intracellular membranes) and microvillar vesicles by the divalent
cation precipitation method [6]. Brieﬂy, the mucosa was homoge-
nized in 10 volumes of 2 mM Tris–HCl, 50 mM mannitol, pH 7.1, con-
taining 10 μg/ml aprotinin and leupeptin. After centrifugation at
500 g, 5 min, MgCl2 was added to the supernatant to yield a ﬁnal con-
centration of 10 mM. After 10 min on ice, the preparation was centri-
fuged at 1500 g, 10 min, to pellet basolateral- and intracellular
membranes. The supernatant was subsequently centrifuged at
48000 g, 30 min, to yield a pellet of microvillar vesicles and a super-
natant of soluble proteins.
For immunoisolation, protein A-Sepharose was swelled in 50 mM
HEPES-HCl, 150 mM NaCl, pH 7.1, (HB) and incubated with anti-
apoA-1 antibodies for 1 h at room temperature under rotation. Before
use, the protein A Sepharose-coupled antibodies were washed three
times in HB. For immunoisolation, Mg2+-precipitated- and microvil-
lar membranes were resuspended in 0.5 ml HB and solubilized by ad-
dition of 1% Triton X-100 at room temperature. After 10 min, the
extracts were cleared by centrifugation at 20000 g, 10 min. ApoA-1
was immunoisolated from the cleared membrane extracts and the
soluble fraction by incubation with ~50 μl protein A Sepharose-
coupled apoA-1 antibody for 1 h at room temperature under rotation.
After incubation, the protein A Sepharose was washed three times in
HB.
2.5. Velocity sedimentation by density gradient centrifugation and deter-
gent resistant membrane (DRM) analysis
For velocity sedimentation, microvillar vesicles were resuspended
in 0.9 ml HB and solubilized by addition of 0.1 ml 10% Triton X-100.
After 10 min incubation at room temperature the preparation was
centrifuged at 20000 g, 10 min, and the resulting supernatant layered
on top of a linear 10–30% sucrose gradient made up in the same buffer
and centrifuged in a SW40Ti rotor (Beckman Instruments, Palo Alto,
USA) at 28000 rpm (gav=97400) for about 20 h at 4 °C, essentially
as previously described [12].
For DRM analysis, microvillar vesicles were resuspended and solu-
bilized with Triton X-100 as described above except that the prepara-
tion was kept on ice throughout the procedure. Flotation of DRMs by
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earlier [13].
After centrifugation, the sucrose gradients were fractionated, and
protein was precipitated from the fractions by addition of an equal
volume of acetone. After 15 min on ice, protein was pelleted by cen-
trifugation at 20000 g, 10 min.2.6. Release of apoA-1 from microvillar membrane vesicles
Microvillar membrane vesicles, freshly prepared as described in
Section 2.4, were brieﬂy washed in HB, pelleted by centrifugation at
20000 g, 40 min, and carefully resuspended in HB. Samples of 50 μl
were immediately used for membrane release experiments with the
following agents: phosphatidylcholine-speciﬁc phospholipase C,
trypsin, high salt (1 M NaCl), bovine whole bile, or sodium taurocho-
late. After incubation at 37 °C, the samples were centrifuged as de-
scribed above, the pellets and supernatants collected and analyzed
by SDS/PAGE followed by immunoblotting.A
B
C
LP
LP
LP
E
E
E
Fig. 1. Localization of apoA-1 and apoB by immunoﬂuorescence microscopy. A, B: Fro-
zen sections of paraformaldehyde-ﬁxed-porcine jejunum from an animal fasted over-
night were labeled for apoA-1, using either an antibody previously described [11]
(A), or a commercial antibody (B). In both cases the brush border (arrows) was labeled
as well as bright punctae scattered in the cytoplasm, probably representing lipopro-
teins awaiting discharge from the cells. In addition, some diffuse labeling of the lamina
propria (LP) was seen. C: A section labeled for apoB showed a similar labeling pattern
in the cytoplasm of the enterocytes as in A and B, but no staining of the brush border.
Bar: 20 μm.2.7. SDS/PAGE and immunoblotting
Samples were denatured by boiling for 3 min in the presence of 1%
SDS and 10 mM dithiothreitol and subjected to SDS/PAGE in 15% gels
as described [32]. After electrophoresis and electrotransfer of proteins
onto Immobilon PVDF membranes, immunoblotting was performed
with primary antibodies to apoA-1 (1:400 dilution) or IAP (1:1000 di-
lution), followed by horseradish peroxidase-coupled secondary anti-
bodies (1:2000 dilution). An electrochemiluminescence (ecl) reagent
was used according to the manufacturer's (GE Healthcare, www.
gehealthcare.com) protocol to develop the blots. After immunoblotting,
total protein was stained with Coomassie brilliant blue R250 (0.2%) dis-
solved in an ethanol/H2O/acetic acid mixture (50:43:7).
2.8. Cholesterol determination
Cholesterol associated with apoA-1, immunoisolated from a mi-
crovillar fraction as described above, was determined spectrophoto-
metrically by a cholesterol oxidase/peroxidase assay [22,25].
3. Results
3.1. ApoA-1 deposition in the enterocyte brush border of overnight fasted
pigs
Fig. 1 shows the localization of apoA-1 in enterocytes of overnight
fasted animals, using either an antibody previously prepared in our
laboratory [11] (Fig. 1A), or a commercially obtained antibody
(Fig. 1B). In both cases, a distinct labeling of the apical brush border
was visible, and in addition, both antibodies brightly labeled punctae
of various sizes scattered in the cytoplasm, most likely representing
lipoproteins awaiting discharge from the cells. No labeling was de-
tectable along the basolateral surfaces, but a diffuse labeling of the
lamina propria, in particular below the basal membrane of the enter-
ocytes, was seen. An antibody to apoB showed much the same label-
ing as that observed for apoA-1, except that the brush border labeling
was absent (Fig. 1C). Together, these results imply that both apolipo-
proteins are assembled into lipoproteins but that only apoA-1 is de-
posited in the brush border during its apical secretion from the
enterocytes in the fasting state. The apical deposition of apoA-1 was
also studied by immunogold electron microscopy, and Fig. 2 shows
prominent apoA-1 labeling of the microvilli of an enterocyte. The apo-
lipoprotein was evenly distributed along the length of the microvilli
and was also seen in small clusters below the cell surface, possibly
representing exocytic vesicles.Fig. 2. Localization of apoA-1 by immunogold electron microscopy. Electron micro-
graph of an ultracryosection showing labeling of apoA-1 in the brush border region
of an enterocyte. The apolipoprotein was seen equally distributed from the bottom to
the tip of the microvilli. In addition clusters of immunogold particles were present in
the apical cytoplasm (arrows), possibly representing exocytic vesicles carrying apoA-
1 to the cell surface. Bar: 0.5 μm.
Fraction: Sol   Mg Mic
1 2 3 1 2 3 1 2 3
50
27
50
42
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Protein
Fig. 3. Immunoisolation of apoA-1 frommucosal subcellular fractions. SDS/PAGE of apoA-
1 immunoisolated from the soluble (Sol), Mg2+-precipitated (Mg)- and microvillar (Mic)
fractions of porcine jejunum, as described in Materials and methods. 1: Total fraction, 2:
protein A-Sepharose immunoisolates, and 3: control protein A-Sepharose without conju-
gated antibodies. After electrophoresis, apoA-1 was visualized by immunoblotting and
total protein by staining with Coomassie brilliant blue. Arrows indicate the position of
apoA-1 (27 kDa), immunoglobulin heavy chains (50 kDa) and actin (42 kDa).
Fraction: P 1 2 3 4 5 6 7 8 9 10 11 12
27 ApoA-1
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ically immunoisolated not only from the soluble- and Mg2-precipitated
fractions, but also from detergent solubilizedmicrovillar vesicles. Finally,
as shown in Table 1, cholesterol was detected in the immunoisolated
microvillar apoA-1, suggesting a close contact between the two
molecules.
We therefore conclude that the brush border labeling for apoA-1
observed both by immunoﬂuorescence- and immunogold microscopy
genuinely represents a deposition of the apolipoprotein at the lumi-
nal surface of the small intestine.Table 1
Detection of cholesterol associated with microvillar apoA-1. ApoA-1 was immunoisolated
from microvillar membranes and subjected to a spectrophotometric cholesterol assay as
described inMaterials andmethods. The absorbance (expressed inmAU) of the immuno-
isolatedmicrovillar apoA-1 (apoA-1 i.p.), a control (antibody-protein A-Sepharose) (anti-
body-PAS control), and a cholesterol standard was determined in parallel. The results
listed in the table are the mean values of two separate experiments.
Sample ApoA-1
i.p.
Antibody-PAS
control
Cholesterol standard
(2.3 μg)
Absorbance (mAU) 14.3 1.8 99.83.2. ApoA-1 in the brush border resides partially in lipid rafts
The enterocyte brush border harbors a large number of digestive en-
zymes [40], and many of them, including aminopeptidase N and
sucrose-isomaltase, reside partially in DRMs, probably owing to cross-
linking to the glycolipids by galectins 2 and 4 [14,15]. As shown in
Fig. 4, some of the brush border-deposited apoA-1 was solubilized by
ice-cold Triton X-100 and remained in the two bottom fractions of the
density gradient, whereas some partitioned with DRMs in the ﬂoating
fractions like IAP, a glycosylphosphatidylinositol-anchored marker of
lipid rafts. Contrary to IAP however, the DRM-associated apoA-1 was
mainly seen in fractions of relative low density, suggesting that it
binds to DRMs having a relative high lipid/protein ratio. Altogether,
the result of the DRM analysis implies that apoA-1 may interact with
both lipid raft- and non-raft domains of the brush border.
Fig. 5 shows a velocity sedimentation experiment performed with
microvillar vesicles extracted by Triton X-100 at room temperature, a
temperature at which also lipid raft microdomains are solubilized.
Here, apoA-1 essentially remained in the two upper fractions of the gra-
dient, indicating that it does not form stable higher molecular weight
complexeswith any resident brush border proteins. Previously, velocity
sedimentation was used to reveal the existence of complexes formed
between microvillar enzymes, such as aminopeptidase N and sucrase-
isomaltase, with galectin-4 [17].3.3. Brush border apoA-1 is released by bile and taurocholate
ApoA-1 has previously been solubilized from the surface of ﬁbro-
blasts by phosphatidylcholine-speciﬁc phospholipase C [27], but as
shown in Fig. 6A, apoA-1 was not readily released from microvillar
vesicles by incubation with this lipase. Similarly, neither incubation
with trypsin nor a wash with 1 M NaCl were effective in releasing
the apolipoprotein, since the small amounts released by all three
agents were similar to that of an integral transmembrane protein,
aminopeptidase N.
TICE is known to be greatly stimulated by using bile salts as choles-
terol acceptors [44,45], and as shown in Fig. 6B, whole bile solubilized
apoA-1 at low concentrations (0.02–0.04%) at which aminopeptidase
N remained associated with the microvillar membrane. The latter pro-
tein required 0.3–0.6% bile for solubilization, a concentration range
that can thus be taken as the one at which the whole membrane
becomes solubilized. Like whole bile, taurocholate was capable of
a selective release of apoA-1 at low concentrations (0.02–0.04%,
corresponding to ~0.4–0.8 mM) (Fig. 6C). Together, these experi-
ments show that apoA-1 is ﬁrmly associated with the brush border
membrane but is readily released by exposure to the physiological
detergents of the digestive tract also known to promote TICE. Fur-
thermore, the low concentrations of bile/taurocholate needed for apoA-
1 release in these in vitro experiments imply that the apolipoprotein67 IAP
DRM’s
Fig. 4. DRM analysis of microvillar apoA-1. Microvillar vesicles were extracted with 1%
Triton X-100 on ice and layered at the bottom of a sucrose gradient for centrifugation
as described in Materials and methods. After centrifugation the gradient was divided
into 12 fractions and a pellet (P) of sedimented protein. ApoA-1 and the 67-kDa DRM
marker IAP (both marked by arrows) were developed by immunoblotting.
Fraction: P 1211 10 9 8 7 6 5 4 3 2 1
Sedimentation
160 
42
27
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27
Apo A-1
Fig. 5. Velocity sedimentation analysis of microvillar apoA-1. Microvillar vesicles were
extracted with 1% Triton X-100 at room temperature and layered on top of a sucrose
gradient for centrifugation as described in Materials and methods. After centrifugation
the gradient was divided into 12 fractions and a pellet (P) of sedimented protein.
ApoA-1 was visualized by immunoblotting and total protein by staining with Coomas-
sie brilliant blue. Arrows indicate the position of apoA-1, actin, and aminopeptidase N
(160 kDa).
Con PLC      Trp 1 M NaCl
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27
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ApN
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P S P S P S P S
P S P S P S P S P S P S
P S P S P S P S P S P S
27
160
120
ApoA-1
ApN
Fig. 6. Release of microvillar apoA-1 by bile and taurocholate. A: Microvillar vesicles
prepared as described in Materials and methods, washed once and resuspended in
50 μl HB in the absence (Con) or presence of 10 U/ml phosphatidylcholine-speciﬁc
phospholipase C (PLC), 50 μg/ml trypsin (Trp) or 1 M NaCl. After incubation for 1 h at
37 °C, the samples were centrifuged at 20000 g, 40 min and the pellet (P) and superna-
tants (S) subjected to SDS/PAGE. ApoA-1 and the 160 kDa- and 120 kDa bands of ami-
nopeptidase N (positions marked by arrows) were visualized by immunoblotting. B, C:
Experimental setup as in A except that the microvillar vesicles were incubated for
10 min at 37 °C with the indicated concentrations of whole bile (B) or sodium tauro-
cholate (C).
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bile constituents, i.e. in the early fasting state.
4. Discussion
Studies on apoA-1 of hepatic origin and as a constituent of HDL
have long established a close relationship between its amphipathic
α-helical structure, enabling it to interact reversibly with lipid sur-
faces [5,48], and its pivotal role in cellular cholesterol efﬂux and RCT
[21]. Regarding the small intestinal apoA-1, its synthesis by entero-
cytes was previously shown to be independent of both the quantity
and quality of dietary triglycerides [20], suggesting other functional
roles for the apolipoprotein in addition to that deﬁned by its partici-
pation in dietary fat absorption [30]. Furthermore, we observed sev-
eral years ago that much of the newly synthesized apoA-1 under
fasting conditions, is secreted apically toward the gut lumen [16],
showing that the small intestine does not contribute all its apoA-1
to the systemic circulation. The main ﬁnding of the present work
was that a fraction of apically secreted lipid free/poor apoA-1 is not
readily released from the cell but instead deposited in the brush bor-
der. A likely scenario for this would be that either during the intracel-
lular transport or exocytosis of a transport vesicle, some but not all of
the apoA-1 molecules within the vesicle become embedded into the
exoplasmic leaﬂet of the membrane. The amphipathic helical struc-
ture of apoA-1 makes the molecule well suited for such a dynamic/
transient association with the membrane, much the same way in
which it operates in RCT [21]. Its resistance to a high-salt wash and
treatment with phospholipase C or trypsin implied that the deposi-
tion is not a mere entrapment in the glycocalyx between the microvil-
li. In addition, the release of apoA-1 by low concentrations of whole
bile or taurocholate is suggestive of a selective and functional interac-
tion with sterol constituents of the bile. Combining these observa-
tions, we therefore propose that apoA-1 in the brush border may
take part in the last step of TICE, the efﬂux of free cholesterol into
the gut lumen prior to the fecal excretion. That cholesterol was
detected in immunoisolated microvillar apoA-1 supports our hypoth-
esis, but admittedly it needs to be conﬁrmed by more in vivo-like ex-
periments. Nevertheless, the following factors also argue in favor ofour proposal: 1) ApoA-1 biosynthesis by the enterocytes constitutes
about 1–2% of the cell's total protein synthesis also in the absence of
triglycerides, with the highest rate of expression in the jejunum
[20]. TICE reportedly occurs throughout the small intestine, but with
the highest rate in the proximal part [43]. The longitudinal expression
proﬁle of apoA-1 thus matches that of TICE, and the ample amounts of
apolipoprotein present have a quantitative potential for mediating re-
moval of physiologically relevant amounts of cholesterol. Further-
more, apoA-1 will mainly be available for TICE during fasting, where
its apical secretion is at the highest level [16]. 2) During apical exocy-
tosis apoA-1 gets in a favorable, close contact with the exoplasmic
leaﬂet of the nascent brush border membrane, thus avoiding having
to penetrate the “unstirred” layer of mucin that faces proteins
approaching the cell surface from the gut lumen. This may be impor-
tant since in a previous work using cultured dog gallbladder cells, ex-
ogenously added apoA-1 failed to promote cellular cholesterol efﬂux
[45]. 3) ApoA-1, either free or as part of HDL, has been shown to in-
hibit cholesterol uptake into isolated microvillar vesicles [4], possibly
via a direct interaction with SR-BI [39]. Although intestinal apoA-1
during fat absorption in vivo is not apically secreted, but mainly
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nevertheless supports the notion that the apolipoprotein is involved
in cholesterol trafﬁc across the brush border. 4) The partial associa-
tion of brush border apoA-1 with DRMs may enhance the lipid efﬂux.
Thus, in studies with model membranes, it was observed that lipid-
free apoA-1 binds tightly to homogeneous phospholipid bilayers,
but is insufﬁcient in lipid removal from them [38]. In contrast, efﬁ-
cient lipid solubilization by apoA-1 occurs from bilayers with a high
degree of interfacial packing defects, i.e. from membranes made of
mixed lipids rich in boundaries between raft- and non-raft microdo-
mains. 5) Only about 10% of the total membrane lipids of porcine mi-
crovillar vesicles are made up of cholesterol [10]. This is less than half
the amounts expected of a “normal” cell membrane, suggesting that
cholesterol levels are actively controlled in the brush border. An
apoA-1-mediated cholesterol efﬂux would contribute by exerting a
cholesterol-lowering effect on the brush border lipid composition al-
though a high proportion of glycosphingolipids in the brush border
may also partly account for this [10].
Considering the many potential candidate proteins for participation
in TICE, none has so far convincingly been shown to play a crucial role in
the process. In the small intestine, the ABCG5/8 heterodimer is known
to be the main transporter in the brush border responsible for sterol ef-
ﬂux [3,33], but double knockouts only showed moderately reduced
levels of fecal neutral sterols [49]. To our knowledge TICE has not
been studied in apoA-1 knockout mice, but in a recent work it was ob-
served that apoA-1 deﬁciency inmice does not affect biliary secretion of
lipids or formation of gallstones [2]. However, when fed a lithogenic
diet, apoA-1 knockout mice exhibited an impaired hypercholesterol-
emic response, suggesting that the apolipoprotein does play a role but
is not a rate-limiting step under normal dietary conditions. We have
previously localized transporters implicated in absorption of dietary/
biliary cholesterol, such as SR-BI and NPClL1, in the porcine brush bor-
der and observed them to be responsive to dietary conditions [23,41].
However, in the presentworkwewere not able to show any convincing
interaction between apoA-1 and these transporters neither by velocity
sedimentation nor by coimmunoprecipitation- or overlay experiments
(results not shown). Since apoA-1 is also capable of mediating a passive
diffusional lipid removal [38], it may conceivably perform in such a sol-
itarymode at the brush border, as suggested by the velocity sedimenta-
tion experiment shown in Fig. 5.
5. Conclusions
Despite its well known ability to remove extrahepatic cellular cho-
lesterol and its key role in RCT, apoA-1 has not previously been con-
sidered a likely candidate protein for TICE. The data presented here
show that cholesterol is associated with immunoisolated microvillar
apoA-1, which by its transient, bile-dependent deposition in the
brush border, is both well placed and well suited to participate func-
tionally in the last step of TICE, i.e. the efﬂux of cholesterol into the
gut lumen in the fasting state. Further studies may help to deﬁne in
greater detail how apoA-1 may achieve this.
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